Abstracts tagged "coronary artery disease and systemic lupus erythematosus (SLE)"

Abstract Number: 1831 • 2015 ACR/ARHP Annual Meeting
Initial Risk Factor Profile and Long-Term Cardiovascular Outcome in Women with Systemic Lupus Erythematosus
Konstantinos Tselios¹, Dafna Gladman², Jiandong Su², Olga Ace³, Arthy Sabapathy³, Anne MacKinnon³ and Murray Urowitz^4,5, ¹Medicine, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ³University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ⁴University of Toronto, Toronto, ON, Canada, ⁵Rheumatology, U of Toronto, Toronto Western Hospital, Toronto, ON, Canada
Background/Purpose: We previously reported the influence of traditional and disease-related risk factors on the development of cardiovascular disease (CVD) in patients with systemic lupus erythematosus…
Abstract Number: 624 • 2013 ACR/ARHP Annual Meeting
Extremely High Coronary Artery Calcium Scores Among Patients With Systemic Lupus Erythematosus
Susan Due Kay¹, Anne Voss², Axel Cosmus Pyndt Diederichsen³ and Mikael Kjær Poulsen⁴, ¹Department of Rheumatology, Odense University hospital, University of Southern Denmark, Odense - 5000, Denmark, ²Dept of Rheumatology, Odense University Hospital, Odense C, Denmark, ³Departmen of Cardiology,, Odense University Hospital, Odens-5000, Denmark, ⁴Department of Cardiology, Odense University Hospital, Odense - 5000, Denmark
Background/Purpose: Investigations of major lupus-cohorts have demonstrated cardiovascular disease to have major impact on morbidity and mortality (Am J Epidemiol 1997;145:408-15). The aim of this…
Abstract Number: 2366 • 2012 ACR/ARHP Annual Meeting
Aortic and Coronary Calcifications in Takayasu Arteritis
Emire Seyahi¹, Ayca Ucgul², Serdal Ugurlu¹, Canan Akman³, Deniz Cebi Olgun³, Sebahattin Yurdakul¹ and Hasan Yazici¹, ¹Rheumatology, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey, ²Internal Medicine, University of Istanbul, Cerrahpasa Medical Faculty, Istanbul, Turkey, ³Radiology, Istanbul University, Cerrahpasa Medical School, Istanbul, Turkey
Aortic and coronary calcifications in Takayasu arteritisBackground/Purpose: We had previously shown, similar to patients with systemic lupus erythematosus (SLE), patients with Takayasu arteritis (TAK) had…
Abstract Number: 1435 • 2012 ACR/ARHP Annual Meeting
Identifying Systemic Lupus Erythematosus Patients At Higher Risk of Coronary Artery Disease
Dominique Ibanez¹, D. D. Gladman² and Murray B. Urowitz¹, ¹Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²Division of Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada
Background/Purpose: There is a high prevalence of premature atherosclerosis among patients with SLE. The traditional Framingham risk score (FRS) identifies few of the SLE patients…
Abstract Number: 1390 • 2012 ACR/ARHP Annual Meeting
Vitamin D Deficiency Is Not Associated with Nor Does It Predict Progression of Coronary Artery Calcium or Carotid Intima-Media Thickness in Systemic Lupus Erythematosus
Adnan Kiani¹, Hong Fang¹, Ehtisham Akhter², Laurence S. Magder³ and Michelle Petri¹, ¹Johns Hopkins University School of Medicine, Baltimore, MD, ²Div of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ³Department of Epidemiology and Public Health, University of Maryland, Baltimore, MD
Background/Purpose: : In the general population, vitamin D deficiency is associated with cardiovascular disease including myocardial infarction and stroke. In SLE, Vitamin D deficiency has…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].